Gauthier George 4
4 · IGM Biosciences, Inc. · Filed Apr 6, 2023
Insider Transaction Report
Form 4
Gauthier George
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2023-04-04+32,500→ 32,500 totalExercise: $12.86Exp: 2033-04-04→ Common Stock (32,500 underlying) - Award
Common Stock
2023-04-04+16,250→ 34,813 total - Sale
Common Stock
2023-04-05$12.60/sh−935$11,781→ 33,878 total
Footnotes (3)
- [F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-fourth of the RSUs shall vest on March 12, 2024 and each one-year anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
- [F2]The sale reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan, entered into on December 29, 2022, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- [F3]1/48 of the shares subject to the option shall vest on April 12, 2023 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.